Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Alizé Pharma III S.A.S. (Alizé Pharma 3)

Alizé Pharma 3 develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Its ambition is to become a leading company in rare diseases with operations in both Europe and the US to support the global development of products. Alizé Pharma 3 is building an innovative and balanced portfolio of products targeting significant unmet medical needs. Its first two assets are AZP3601, a PTH analog for hypoparathyroidism, and AZP-3404, a peptide leveraging the biology of IGFBP2 for treating syndromes of severe insulin resistance. *

 

Period Start 2014-12-01 established
Period End 2020-06-02 renamed
  Group AstraZeneca (Group)
  Today Amolyt Pharma S.A.S.
  Successor Amolyt Pharma S.A.S.
Product Industry peptide-based drug
Person Person Abribat, Thierry (Alizé Pharma 2007– President + Founder)
     
Region Region Lyon
  Country France
  Street 15 chemin du Saquin
Espace Européen, Building G
  City 69130 Ecully
  Tel +33-4-7218-9428
    Address record changed: 2022-10-10
     
Basic data Employees n. a.
     
    * Document for »About Section«: Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon.
     
   
Record changed: 2024-03-20

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for AstraZeneca (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top